JESSICA ADAMS: Open Payments
NPI 1174278030 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,094 in 150 payments from 18 companies in 2025. Trend: 2023 $2,500 · 2024 $2,978 · 2025 $3,094
Food & beverage: $2,956Education: $138
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $509 |
| Janssen Biotech, Inc. | 16 | $382 |
| ABBVIE INC. | 21 | $354 |
| Novartis Pharmaceuticals Corporation | 18 | $332 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $210 |
| GENZYME CORPORATION | 6 | $181 |
| PFIZER INC. | 7 | $166 |
| Galderma Laboratories, L.P. | 16 | $165 |
| Incyte Corporation | 7 | $153 |
| LEO Pharma Inc. | 2 | $119 |
Products named: Bimzelx, TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, COSENTYX, OPZELURA.
Industry payments across TN — which companies pay providers there.
